Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma

Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with prima...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Immunology, Immunotherapy Immunotherapy, 2008-01, Vol.57 (1), p.97-106
Hauptverfasser: Hillen, Femke, Baeten, Coen I. M., van de Winkel, Anouk, Creytens, David, van der Schaft, Daisy W. J., Winnepenninckx, Véronique, Griffioen, Arjan W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106
container_issue 1
container_start_page 97
container_title Cancer Immunology, Immunotherapy
container_volume 57
creator Hillen, Femke
Baeten, Coen I. M.
van de Winkel, Anouk
Creytens, David
van der Schaft, Daisy W. J.
Winnepenninckx, Véronique
Griffioen, Arjan W.
description Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with primary cutaneous melanoma. The presence of T lymphocytes, cytotoxic T lymphocytes, B lymphocytes, CD16+ cells and macrophages was correlated to Breslow depth. A significantly higher amount of several subsets of leukocytes was found in samples with a more progressed tumor stage and survival analysis demonstrated that a higher amount of T lymphocytes and CD16+ cells was associated with a short survival. The amount of FOXP3+ regulatory T lymphocytes did not correlate with survival, nevertheless, it correlated with the amount of total infiltrate. In contrast, analysis of the expression of CD69, a marker for activated lymphocytes, demonstrated that patients with a higher amount of CD69+ lymphocytes had a better survival. In addition, a new parameter for aggressiveness of melanoma, tumor cell plasticity [i.e., the presence of periodic acid Schiff’s (PAS) reagent positive loops], also predicted short survival and a trend of a higher amount of tumor infiltrating leukocytes in tumors with PAS positive loops was observed. These findings demonstrate that leukocyte infiltration and the presence of PAS loops is a sign of tumor aggressiveness and may have prognostic value.
doi_str_mv 10.1007/s00262-007-0353-9
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11030822</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1376376451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-84d446b29ad26623abc45c7d7b4c2ee7355da07e4c4829ec01453a81944c94c73</originalsourceid><addsrcrecordid>eNp1kV2L1TAQhoMo7tnVH-CNBEHvqvlq2l6JLLoKB7zR6zAnnR6ztskxSRfOvzelZVcFr2bIPDOZd15CXnD2ljPWvEuMCS2qklZM1rLqHpEdV7K8tDV_THZMKlY1jKkLcpnSbUkE67qn5II3mgkh6h0Je5x_BnvOSJ0f3JgjZBc8Bd_TPE8hUovjSE8jpOysy2cKEekJIkyYMSYaBgrHY8SU3B36Esoceopugnimds7gMcyJTjiCDxM8I08GGBM-3-IV-f7p47frz9X-682X6w_7ytaC56pVvVL6IDrohdZCwsGq2jZ9c1BWIDayrntgDSqrWtGhZVzVElreKWU7ZRt5Rd6vc0_zYcLeoi_KRrMtZgI483fFux_mGO4M50yyVogy4c02IYZfM6ZsJpeWY6yKTLlr22gtC_jqH_A2zNEXdUZwWXOmdVsgvkI2hpQiDvercGYWM81qplnSxUzTlZ6Xf2p46NjcK8DrDYBkYRwieOvSPSeWq2ihCidWLpWSP2J82PD_v_8G2XC5fg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213510668</pqid></control><display><type>article</type><title>Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>PubMed Central</source><creator>Hillen, Femke ; Baeten, Coen I. M. ; van de Winkel, Anouk ; Creytens, David ; van der Schaft, Daisy W. J. ; Winnepenninckx, Véronique ; Griffioen, Arjan W.</creator><creatorcontrib>Hillen, Femke ; Baeten, Coen I. M. ; van de Winkel, Anouk ; Creytens, David ; van der Schaft, Daisy W. J. ; Winnepenninckx, Véronique ; Griffioen, Arjan W.</creatorcontrib><description>Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with primary cutaneous melanoma. The presence of T lymphocytes, cytotoxic T lymphocytes, B lymphocytes, CD16+ cells and macrophages was correlated to Breslow depth. A significantly higher amount of several subsets of leukocytes was found in samples with a more progressed tumor stage and survival analysis demonstrated that a higher amount of T lymphocytes and CD16+ cells was associated with a short survival. The amount of FOXP3+ regulatory T lymphocytes did not correlate with survival, nevertheless, it correlated with the amount of total infiltrate. In contrast, analysis of the expression of CD69, a marker for activated lymphocytes, demonstrated that patients with a higher amount of CD69+ lymphocytes had a better survival. In addition, a new parameter for aggressiveness of melanoma, tumor cell plasticity [i.e., the presence of periodic acid Schiff’s (PAS) reagent positive loops], also predicted short survival and a trend of a higher amount of tumor infiltrating leukocytes in tumors with PAS positive loops was observed. These findings demonstrate that leukocyte infiltration and the presence of PAS loops is a sign of tumor aggressiveness and may have prognostic value.</description><identifier>ISSN: 0340-7004</identifier><identifier>EISSN: 1432-0851</identifier><identifier>DOI: 10.1007/s00262-007-0353-9</identifier><identifier>PMID: 17602225</identifier><identifier>CODEN: CIIMDN</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Angiogenesis ; Antigens, CD - biosynthesis ; Antigens, Differentiation, T-Lymphocyte - biosynthesis ; Antineoplastic agents ; Biological and medical sciences ; Cancer ; Cancer Research ; Dermatology ; Female ; Humans ; Immunohistochemistry ; Immunology ; Immunotherapy ; Lectins, C-Type ; Leukocytes ; Lymphocyte Activation - immunology ; Lymphocyte Subsets - immunology ; Lymphocyte Subsets - metabolism ; Lymphocytes ; Lymphocytes, Tumor-Infiltrating - immunology ; Lymphocytes, Tumor-Infiltrating - metabolism ; Macrophages - immunology ; Male ; Medical prognosis ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Melanoma ; Melanoma - blood supply ; Melanoma - immunology ; Melanoma - pathology ; Metastasis ; Neoplasm Staging ; Neovascularization, Pathologic ; Oncology ; Original ; Original Article ; Patients ; Pharmacology. Drug treatments ; Prognosis ; Skin Neoplasms - blood supply ; Skin Neoplasms - immunology ; Skin Neoplasms - pathology ; Survival Analysis ; Tumors ; Tumors of the skin and soft tissue. Premalignant lesions</subject><ispartof>Cancer Immunology, Immunotherapy, 2008-01, Vol.57 (1), p.97-106</ispartof><rights>Springer-Verlag 2007</rights><rights>2008 INIST-CNRS</rights><rights>Springer-Verlag 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-84d446b29ad26623abc45c7d7b4c2ee7355da07e4c4829ec01453a81944c94c73</citedby><cites>FETCH-LOGICAL-c521t-84d446b29ad26623abc45c7d7b4c2ee7355da07e4c4829ec01453a81944c94c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11030822/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11030822/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,41467,42536,51298,53770,53772</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20145624$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17602225$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hillen, Femke</creatorcontrib><creatorcontrib>Baeten, Coen I. M.</creatorcontrib><creatorcontrib>van de Winkel, Anouk</creatorcontrib><creatorcontrib>Creytens, David</creatorcontrib><creatorcontrib>van der Schaft, Daisy W. J.</creatorcontrib><creatorcontrib>Winnepenninckx, Véronique</creatorcontrib><creatorcontrib>Griffioen, Arjan W.</creatorcontrib><title>Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma</title><title>Cancer Immunology, Immunotherapy</title><addtitle>Cancer Immunol Immunother</addtitle><addtitle>Cancer Immunol Immunother</addtitle><description>Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with primary cutaneous melanoma. The presence of T lymphocytes, cytotoxic T lymphocytes, B lymphocytes, CD16+ cells and macrophages was correlated to Breslow depth. A significantly higher amount of several subsets of leukocytes was found in samples with a more progressed tumor stage and survival analysis demonstrated that a higher amount of T lymphocytes and CD16+ cells was associated with a short survival. The amount of FOXP3+ regulatory T lymphocytes did not correlate with survival, nevertheless, it correlated with the amount of total infiltrate. In contrast, analysis of the expression of CD69, a marker for activated lymphocytes, demonstrated that patients with a higher amount of CD69+ lymphocytes had a better survival. In addition, a new parameter for aggressiveness of melanoma, tumor cell plasticity [i.e., the presence of periodic acid Schiff’s (PAS) reagent positive loops], also predicted short survival and a trend of a higher amount of tumor infiltrating leukocytes in tumors with PAS positive loops was observed. These findings demonstrate that leukocyte infiltration and the presence of PAS loops is a sign of tumor aggressiveness and may have prognostic value.</description><subject>Angiogenesis</subject><subject>Antigens, CD - biosynthesis</subject><subject>Antigens, Differentiation, T-Lymphocyte - biosynthesis</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Dermatology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Immunology</subject><subject>Immunotherapy</subject><subject>Lectins, C-Type</subject><subject>Leukocytes</subject><subject>Lymphocyte Activation - immunology</subject><subject>Lymphocyte Subsets - immunology</subject><subject>Lymphocyte Subsets - metabolism</subject><subject>Lymphocytes</subject><subject>Lymphocytes, Tumor-Infiltrating - immunology</subject><subject>Lymphocytes, Tumor-Infiltrating - metabolism</subject><subject>Macrophages - immunology</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Melanoma</subject><subject>Melanoma - blood supply</subject><subject>Melanoma - immunology</subject><subject>Melanoma - pathology</subject><subject>Metastasis</subject><subject>Neoplasm Staging</subject><subject>Neovascularization, Pathologic</subject><subject>Oncology</subject><subject>Original</subject><subject>Original Article</subject><subject>Patients</subject><subject>Pharmacology. Drug treatments</subject><subject>Prognosis</subject><subject>Skin Neoplasms - blood supply</subject><subject>Skin Neoplasms - immunology</subject><subject>Skin Neoplasms - pathology</subject><subject>Survival Analysis</subject><subject>Tumors</subject><subject>Tumors of the skin and soft tissue. Premalignant lesions</subject><issn>0340-7004</issn><issn>1432-0851</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kV2L1TAQhoMo7tnVH-CNBEHvqvlq2l6JLLoKB7zR6zAnnR6ztskxSRfOvzelZVcFr2bIPDOZd15CXnD2ljPWvEuMCS2qklZM1rLqHpEdV7K8tDV_THZMKlY1jKkLcpnSbUkE67qn5II3mgkh6h0Je5x_BnvOSJ0f3JgjZBc8Bd_TPE8hUovjSE8jpOysy2cKEekJIkyYMSYaBgrHY8SU3B36Esoceopugnimds7gMcyJTjiCDxM8I08GGBM-3-IV-f7p47frz9X-682X6w_7ytaC56pVvVL6IDrohdZCwsGq2jZ9c1BWIDayrntgDSqrWtGhZVzVElreKWU7ZRt5Rd6vc0_zYcLeoi_KRrMtZgI483fFux_mGO4M50yyVogy4c02IYZfM6ZsJpeWY6yKTLlr22gtC_jqH_A2zNEXdUZwWXOmdVsgvkI2hpQiDvercGYWM81qplnSxUzTlZ6Xf2p46NjcK8DrDYBkYRwieOvSPSeWq2ihCidWLpWSP2J82PD_v_8G2XC5fg</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Hillen, Femke</creator><creator>Baeten, Coen I. M.</creator><creator>van de Winkel, Anouk</creator><creator>Creytens, David</creator><creator>van der Schaft, Daisy W. J.</creator><creator>Winnepenninckx, Véronique</creator><creator>Griffioen, Arjan W.</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080101</creationdate><title>Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma</title><author>Hillen, Femke ; Baeten, Coen I. M. ; van de Winkel, Anouk ; Creytens, David ; van der Schaft, Daisy W. J. ; Winnepenninckx, Véronique ; Griffioen, Arjan W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-84d446b29ad26623abc45c7d7b4c2ee7355da07e4c4829ec01453a81944c94c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Angiogenesis</topic><topic>Antigens, CD - biosynthesis</topic><topic>Antigens, Differentiation, T-Lymphocyte - biosynthesis</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Dermatology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Immunology</topic><topic>Immunotherapy</topic><topic>Lectins, C-Type</topic><topic>Leukocytes</topic><topic>Lymphocyte Activation - immunology</topic><topic>Lymphocyte Subsets - immunology</topic><topic>Lymphocyte Subsets - metabolism</topic><topic>Lymphocytes</topic><topic>Lymphocytes, Tumor-Infiltrating - immunology</topic><topic>Lymphocytes, Tumor-Infiltrating - metabolism</topic><topic>Macrophages - immunology</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Melanoma</topic><topic>Melanoma - blood supply</topic><topic>Melanoma - immunology</topic><topic>Melanoma - pathology</topic><topic>Metastasis</topic><topic>Neoplasm Staging</topic><topic>Neovascularization, Pathologic</topic><topic>Oncology</topic><topic>Original</topic><topic>Original Article</topic><topic>Patients</topic><topic>Pharmacology. Drug treatments</topic><topic>Prognosis</topic><topic>Skin Neoplasms - blood supply</topic><topic>Skin Neoplasms - immunology</topic><topic>Skin Neoplasms - pathology</topic><topic>Survival Analysis</topic><topic>Tumors</topic><topic>Tumors of the skin and soft tissue. Premalignant lesions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hillen, Femke</creatorcontrib><creatorcontrib>Baeten, Coen I. M.</creatorcontrib><creatorcontrib>van de Winkel, Anouk</creatorcontrib><creatorcontrib>Creytens, David</creatorcontrib><creatorcontrib>van der Schaft, Daisy W. J.</creatorcontrib><creatorcontrib>Winnepenninckx, Véronique</creatorcontrib><creatorcontrib>Griffioen, Arjan W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer Immunology, Immunotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hillen, Femke</au><au>Baeten, Coen I. M.</au><au>van de Winkel, Anouk</au><au>Creytens, David</au><au>van der Schaft, Daisy W. J.</au><au>Winnepenninckx, Véronique</au><au>Griffioen, Arjan W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma</atitle><jtitle>Cancer Immunology, Immunotherapy</jtitle><stitle>Cancer Immunol Immunother</stitle><addtitle>Cancer Immunol Immunother</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>57</volume><issue>1</issue><spage>97</spage><epage>106</epage><pages>97-106</pages><issn>0340-7004</issn><eissn>1432-0851</eissn><coden>CIIMDN</coden><abstract>Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with primary cutaneous melanoma. The presence of T lymphocytes, cytotoxic T lymphocytes, B lymphocytes, CD16+ cells and macrophages was correlated to Breslow depth. A significantly higher amount of several subsets of leukocytes was found in samples with a more progressed tumor stage and survival analysis demonstrated that a higher amount of T lymphocytes and CD16+ cells was associated with a short survival. The amount of FOXP3+ regulatory T lymphocytes did not correlate with survival, nevertheless, it correlated with the amount of total infiltrate. In contrast, analysis of the expression of CD69, a marker for activated lymphocytes, demonstrated that patients with a higher amount of CD69+ lymphocytes had a better survival. In addition, a new parameter for aggressiveness of melanoma, tumor cell plasticity [i.e., the presence of periodic acid Schiff’s (PAS) reagent positive loops], also predicted short survival and a trend of a higher amount of tumor infiltrating leukocytes in tumors with PAS positive loops was observed. These findings demonstrate that leukocyte infiltration and the presence of PAS loops is a sign of tumor aggressiveness and may have prognostic value.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>17602225</pmid><doi>10.1007/s00262-007-0353-9</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-7004
ispartof Cancer Immunology, Immunotherapy, 2008-01, Vol.57 (1), p.97-106
issn 0340-7004
1432-0851
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11030822
source MEDLINE; SpringerLink Journals; PubMed Central
subjects Angiogenesis
Antigens, CD - biosynthesis
Antigens, Differentiation, T-Lymphocyte - biosynthesis
Antineoplastic agents
Biological and medical sciences
Cancer
Cancer Research
Dermatology
Female
Humans
Immunohistochemistry
Immunology
Immunotherapy
Lectins, C-Type
Leukocytes
Lymphocyte Activation - immunology
Lymphocyte Subsets - immunology
Lymphocyte Subsets - metabolism
Lymphocytes
Lymphocytes, Tumor-Infiltrating - immunology
Lymphocytes, Tumor-Infiltrating - metabolism
Macrophages - immunology
Male
Medical prognosis
Medical sciences
Medicine
Medicine & Public Health
Melanoma
Melanoma - blood supply
Melanoma - immunology
Melanoma - pathology
Metastasis
Neoplasm Staging
Neovascularization, Pathologic
Oncology
Original
Original Article
Patients
Pharmacology. Drug treatments
Prognosis
Skin Neoplasms - blood supply
Skin Neoplasms - immunology
Skin Neoplasms - pathology
Survival Analysis
Tumors
Tumors of the skin and soft tissue. Premalignant lesions
title Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T08%3A04%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leukocyte%20infiltration%20and%20tumor%20cell%20plasticity%20are%20parameters%20of%20aggressiveness%20in%20primary%20cutaneous%20melanoma&rft.jtitle=Cancer%20Immunology,%20Immunotherapy&rft.au=Hillen,%20Femke&rft.date=2008-01-01&rft.volume=57&rft.issue=1&rft.spage=97&rft.epage=106&rft.pages=97-106&rft.issn=0340-7004&rft.eissn=1432-0851&rft.coden=CIIMDN&rft_id=info:doi/10.1007/s00262-007-0353-9&rft_dat=%3Cproquest_pubme%3E1376376451%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=213510668&rft_id=info:pmid/17602225&rfr_iscdi=true